Organization
Mitsubishi Tanabe Pharma Corp.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Mitsubishi Tanabe Pharma Corp.
... Overview: Vraylar" report has been added to ResearchAndMarkets.com's offering. Vraylar (cariprazine; Gedeon Richter/Allergan/Mitsubishi Tanabe) is a novel atypical antipsychotic with partial agonistic activity at D2 ...
... Invokana" report has been added to ResearchAndMarkets.com's offering. Invokana (canagliflozin; Johnson & Johnson/Mitsubishi Tanabe/Daiichi Sankyo) is a member of the novel sodium-glucose cotransporter-2 (SGLT-2) inhibitor ...
... "Drug Overview: MIN-101" report has been added to ResearchAndMarkets.com's offering. MIN-101 (Minerva Neurosciences/Mitsubishi Tanabe) is a novel antagonist of the sigma-2 and serotonin 5-HT2A receptors. ...
... which is distributed by Mochida Pharmaceutical Co., Ltd. (Mochida) and Mitsubishi Tanabe Pharma Corporation (Mitsubishi Tanabe) in Japan, is expected to receive a final confirmation ...
... drug pipelines has been added to ResearchAndMarkets.com's offering. Invokana (canagliflozin; Johnson & Johnson/Mitsubishi Tanabe/Daiichi Sankyo) is a member of the novel sodium-glucose cotransporter-2 (SGLT-2) inhibitor ...
... Africa have the lowest incidence (0.62 and 0.89 cases per 100,000 people, respectively).Mitsubishi Tanabe's Radicava (edaravone), Concordia's Rilutek (riluzole), and Corestem's Neuronata-R are the only ...
... signed in 2018, including the Israel Institute for Biological Research and Mitsubishi Tanabe Pharma which we recently announced. These results demonstrate that our business development ...
... surrounding axons in MS.Gilenya is a once-daily oral capsule developed by Mitsubishi Tanabe Pharma. In 1997, Novartis obtained exclusive worldwide development rights, except in Japan, ...
... million revenue recognized from our collaboration agreements with AbbVie and Mitsubishi Tanabe Pharma Corporation (Mitsubishi Tanabe). No similar net product sales were reported for the ...
... million revenue recognized from our collaboration agreements with AbbVie and Mitsubishi Tanabe Pharma Corporation (Mitsubishi Tanabe). No similar net product sales were reported for the ...
Subscribe now for full coverage on Mitsubishi Tanabe Pharma Corp.
Start My Free Trial